Sitaxentan sodium

This classification denotes an endothelin-1 protein receptor antagonist C18H14ClN2O6S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6V9JH46E20, chemically known as n-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-(2-(6-methyl-2h-1,3-benzodioxol-5-yl)acetyl)thiophene-3-sulfonamide sodium salt, but more generally known as sitaxentan sodium, which bears US NIH Compound Identifier 11477084. European Medicines Agency schedules Sitaxentan sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22351. Most nations, for tariff and trade purposes, schedule sitaxentan sodium under HS 29350090 and SITC 51580. As of Q4 2014, SITAXENTAN SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CC1CC2C(CC1CC(=O)C3C(CCS3)S(=O)(=O)[N-]C4C(C(NO4)C)CL)OCO2.[NA+].